title: Novel biomarkers in heart failure: usefulness in clinical practice.
abstract: Biomarkers have become an increasingly important tool in clinical practice, helping to improve patient care. In heart failure (HF), brain natriuretic peptide and N-terminal prohormone of the brain natriuretic peptide have been widely applied in prognosis, clinical diagnosis and treatment. Recently, several novel biomarkers have been examined on their efficacy to improve diagnosis, determine the pathophysiologic state of HF, improve clinical decision making, clinical outcome, guide treatment and assess prognosis of HF patients. In this special report, the authors summarize the usefulness and significance of the most promising novel biomarkers in patients with HF.
authors.affiliation: Department of Biological Chemistry, University of Athens Medical School, Athens, Greece.
authors.forename: Gerasimos
authors.initials: G
authors.lastname: Siasos
authors.forename: Dimitris
authors.initials: D
authors.lastname: Tousoulis
authors.forename: Evangelos
authors.initials: E
authors.lastname: Oikonomou
authors.forename: Eleni
authors.initials: E
authors.lastname: Kokkou
authors.forename: Savvas
authors.initials: S
authors.lastname: Mazaris
authors.forename: Theodosia
authors.initials: T
authors.lastname: Konsola
authors.forename: Christodoulos
authors.initials: C
authors.lastname: Stefanadis
mesh_terms: D015415:Biomarkers / Q000097:blood; D006333:Heart Failure / Q000175:diagnosis* / Q000628:therapy*; D006801:Humans; D007249:Inflammation / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D035683:MicroRNAs / Q000097:blood*; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D011379:Prognosis
chemical_list: D015415:Biomarkers; D035683:MicroRNAs; D020097:Natriuretic Peptide, Brain